Catalytic utilization of eIF-2 and mRNA binding proteins are limiting in lysates from vesicular stomatitis virus infected L cells

Biochemistry ◽  
1984 ◽  
Vol 23 (25) ◽  
pp. 6184-6190 ◽  
Author(s):  
Ella Dratewka-Kos ◽  
Ibolya Kiss ◽  
Jean Lucas-Lenard ◽  
Harshvardhan B. Mehta ◽  
Charles L. Woodley ◽  
...  
2019 ◽  
Author(s):  
Kathrin Bajak ◽  
Kevin Leiss ◽  
Christine Clayton ◽  
Esteban Erben

AbstractKinetoplastids rely heavily on post-transcriptional mechanisms for control of gene expression, and on RNA-binding proteins that regulate mRNA splicing, translation and decay. Trypanosoma brucei ERBP1 (Tb927.10.14150) and ERBP2 (Tb927.9.9550) were previously identified as mRNA binding proteins that lack canonical RNA-binding domains. We here show that ERBP1 is associated with the endoplasmic reticulum, like ERBP2, and that the two proteins interact in vivo. Loss of ERBP1 from bloodstream-form T. brucei initially resulted in a growth defect but proliferation was restored after more prolonged cultivation. Results from a pull-down of tagged ERBP1 suggest that it preferentially binds to ribosomal protein mRNAs. The ERBP1 sequence resembles that of Saccharomyces cerevisiae Bfr1, which also localises to the endoplasmic reticulum and binds to ribosomal protein mRNAs. However, unlike Bfr1, ERBP1 does not bind to mRNAs encoding secreted proteins, and it is also not recruited to stress granules after starvation.


2014 ◽  
Vol 2014 ◽  
pp. 1-7 ◽  
Author(s):  
Xinxin Liu ◽  
Hua Ye ◽  
Liuxia Li ◽  
Wenjie Li ◽  
Yi Zhang ◽  
...  

Ovarian cancer is one of the leading causes of cancer-related deaths among women. There is an urgent need of better approaches for the identification of appropriate biomarkers in the early detection of ovarian cancer. The aim of this study was to elucidate the significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins (IMPs) in patients with ovarian cancer. In this study, autoantibody responses to two members (IMP1 and p62/IMP2) of IMPs were evaluated by enzyme-linked immunosorbent assay (ELISA), western blotting, and indirect immunofluorescence assay in sera from patients with ovarian cancer and normal human individuals. The results have demonstrated that both IMP1 and p62/IMP2 can induce relatively higher frequency of autoantibody responses in patients with ovarian cancer (26.5% and 29.4%) compared to normal individuals(P<0.01). Our preliminary data suggest that IMP1 and p62/IMP2 can stimulate autoimmune responses in ovarian cancer, and anti-IMP1 and anti-p62/IMP2 autoantibodies could be used as potential biomarkers in immunodiagnosis of ovarian cancer.


2012 ◽  
Vol 70 (15) ◽  
pp. 2657-2675 ◽  
Author(s):  
Jessica L. Bell ◽  
Kristin Wächter ◽  
Britta Mühleck ◽  
Nikolaos Pazaitis ◽  
Marcel Köhn ◽  
...  

1993 ◽  
Vol 212 (1) ◽  
pp. 217-225 ◽  
Author(s):  
Kathryn SHARPLESS ◽  
Diane BIEGEL ◽  
Tao YANG ◽  
Joel S. PACHTER

2008 ◽  
Vol 7 (6) ◽  
pp. 555-564 ◽  
Author(s):  
Sergi Puig ◽  
Sandra V. Vergara ◽  
Dennis J. Thiele

Cell ◽  
2000 ◽  
Vol 102 (2) ◽  
pp. 135-138 ◽  
Author(s):  
Ann-Bin Shyu ◽  
Miles F Wilkinson

Sign in / Sign up

Export Citation Format

Share Document